awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33750154-22AC6C77-C4BE-44BA-8A38-8464CD13CCC5
Q33750154-22AC6C77-C4BE-44BA-8A38-8464CD13CCC5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33750154-22AC6C77-C4BE-44BA-8A38-8464CD13CCC5
Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial
P2860
Q33750154-22AC6C77-C4BE-44BA-8A38-8464CD13CCC5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33750154-22AC6C77-C4BE-44BA-8A38-8464CD13CCC5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a8b250bcd2cd740822d909a7b7089df50db9f3b7
P2860
The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients